Literature DB >> 33165052

CORR Insights®: Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?

Terri A Zachos1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33165052      PMCID: PMC7899422          DOI: 10.1097/CORR.0000000000001546

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.755


× No keyword cloud information.
  11 in total

Review 1.  BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk.

Authors:  Kohei Miyazono; Shingo Maeda; Takeshi Imamura
Journal:  Cytokine Growth Factor Rev       Date:  2005-06       Impact factor: 7.638

2.  Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6.

Authors:  Terri A Zachos; Kathleen M Shields; Alicia L Bertone
Journal:  J Orthop Res       Date:  2006-06       Impact factor: 3.494

3.  Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2.

Authors:  David S Geller; Michael Y Singh; Wendong Zhang; Jonathan Gill; Michael E Roth; Mimi Y Kim; Xianhong Xie; Christopher K Singh; Howard D Dorfman; Esperanza Villanueva-Siles; Amy Park; Sajida Piperdi; Richard Gorlick
Journal:  Clin Cancer Res       Date:  2014-12-03       Impact factor: 12.531

4.  "To B(MP-2) or Not To B(MP-2)" or "Much Ado About Nothing": Are Orthobiologics in Tumor Surgery Worth the Risks?

Authors:  Kurt R Weiss
Journal:  Clin Cancer Res       Date:  2015-01-21       Impact factor: 12.531

Review 5.  Canine sarcomas as a surrogate for the human disease.

Authors:  Daniel L Gustafson; Dawn L Duval; Daniel P Regan; Douglas H Thamm
Journal:  Pharmacol Ther       Date:  2018-03-09       Impact factor: 12.310

6.  Mesenchymal stem cell-mediated gene delivery of bone morphogenetic protein-2 in an articular fracture model.

Authors:  Terri Zachos; Alisha Diggs; Steven Weisbrode; Jeffrey Bartlett; Alicia Bertone
Journal:  Mol Ther       Date:  2007-05-22       Impact factor: 11.454

7.  Clinical, Pathological, and Ethical Considerations for the Conduct of Clinical Trials in Dogs with Naturally Occurring Cancer: A Comparative Approach to Accelerate Translational Drug Development.

Authors:  Daniel Regan; Kelly Garcia; Douglas Thamm
Journal:  ILAR J       Date:  2018-12-01

8.  Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2.

Authors:  Xiao Yang; Ya-ping Wang; Feng-xiang Liu; Ke Zeng; Ming-quan Qian; Gang Chen; Lei Shi; Guo-xing Zhu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-03-22       Impact factor: 2.416

9.  Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?

Authors:  Joseph K Kendal; Arvind Singla; Asmaa Affan; Kurt Hildebrand; Abdullah Al-Ani; Mark Ungrin; Douglas J Mahoney; Doha Itani; Frank R Jirik; Michael J Monument
Journal:  Clin Orthop Relat Res       Date:  2020-12       Impact factor: 4.755

10.  Identification of co-expression modules and pathways correlated with osteosarcoma and its metastasis.

Authors:  Jian-Sheng Wang; Yun-Guo Wang; Yong-Sheng Zhong; Xue-Dong Li; Shi-Xin Du; Peng Xie; Gui-Zhou Zheng; Jing-Ming Han
Journal:  World J Surg Oncol       Date:  2019-03-08       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.